Efficacy of Anthocyanin from Curly Kale Extract on the Reduction of Oxidative Stress in Patients with Lymphoma After Treated with CHOP or CHOP-like Regimen A Randomized Placebo-Controlled Study

Phase 3

Completed

• Conditions: Patients with lymphoma who recently treatment with CHOP or CHOP-like regimens within 60 days; Lymphoma; Antioxidant; Curly kale; anthocyanin

• Registration Number: TCTR20230619003
• Lead Sponsor: Faculty of Medicine, Chiang Mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-03-21
• Study Start: 2023-06-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

1) Patients age 18 years old and above
2) Diagnosed with lymphoma and recently completed treatment with CHOP or CHOP-liked chemotherapy within 60 days
3) ECOG performance status 0-2

Exclusion Criteria

1)Patients who need to be treated with further chemotherapy within 2 month
2)Patients who are not able to take oral medication
3)History of allergic to Curly Kale
4)Inability or unwillingness to give consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
oxidative marker reduction 2 months malondialdehyde (MDA)

Secondary Outcome Measures

Name	Time	Method
antioxidant increment 2 months superoxide dismutase (SOD)